# Sharps Technology signs sales agreements for SecureGard syringes with European medical supply company

Sharps Technology has signed multiple sales agreements with a prominent European medical supply company to sell its SecureGard syringe inventory. Initial shipments and revenue began in early December 2024, with new production orders starting in Q2 2025.

- Type: Contract
- Announced: 2024-12-05
- Where: Hungary, Hungary
- Value: $50.0M
- Status: announced
- Capacity: 35 million units
- Products: SecureGard safety syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sharps Technology](https://endata.com/companies/11050.md)

## Sources

- [nasdaq.com](https://www.nasdaq.com/press-release/sharps-technologys-ceo-issues-shareholder-letter-highlighting-hungary-manufacturing), 2024-12-05: "The execution of this five-year Sales Agreement creates a manufacturing demand for at least 500 million syringes and completely sells out the currently available manufacturing capacity for Sharps’ 10mL SoloGard syringes."
- [biopharmawatch.com](https://www.biopharmawatch.com/news/STSS/sharps-technology-s-ceo-issues-shareholder-letter-highlighting-hungary-manufacturing-facil-stss-20241205), 2024-12-05: "The execution of this five-year Sales Agreement creates a manufacturing demand for at least 500 million syringes and completely sells out the currently available manufacturing capacity for Sharps’ 10mL SoloGard syringes."
- [theglobeandmail.com](https://www.theglobeandmail.com/investing/markets/stocks/STSS/pressreleases/29910649/sharps-technology-signs-sales-agreements-to-support-major-european-healthcare-network-and-sells-out-its-inventory-for-securegard/), 2024-12-05: "The customer plans to purchase Sharps’ entire existing inventory of 1mL and 3mL SecureGard inventory warehoused in Hungary."
- [globenewswire.com](https://www.globenewswire.com/news-release/2024/12/05/2992458/0/en/Sharps-Technology-s-CEO-Issues-Shareholder-Letter-Highlighting-Hungary-Manufacturing-Facility-Expansion-Plans-to-Increase-SecureGard-and-SoloGard-Product-Supply-and-Revenue.html), 2024-12-05: "The execution of this five-year Sales Agreement creates a manufacturing demand for at least 500 million syringes and completely sells out the currently available manufacturing capacity for Sharps’ 10mL SoloGard syringes."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.